ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, Inc. today announced four poster presentations associated with suprachoroidal drug administration will be presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), May 1-5, 2016, in Seattle, WA.
The following poster presentations are scheduled during the ARVO Annual Meeting:
• Patel S, Kissner J, Zarnitsyn V, Farjo R, Noronha G. Efficacy of Suprachoroidal Aflibercept in a Laser Induced Choroidal Neovascularization Model. [286-B0319. May 1, 8:30 a.m.-10:15 a.m., Exhibit Hall]
The following poster presentations are scheduled during the ARVO Annual Meeting:
• Patel S, Kissner J, Zarnitsyn V, Farjo R, Noronha G. Efficacy of Suprachoroidal Aflibercept in a Laser Induced Choroidal Neovascularization Model. [286-B0319. May 1, 8:30 a.m.-10:15 a.m., Exhibit Hall]
